Gabriela Hernández-Galicia

Dr. Gabriela Hernández-Galicia

orcid

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 January 2023 in Journal of Leukocyte Biology
Verified
Journal Article
Open access
PDF file
RCRamón Castellanos-Martínez
Ramón Castellanos-Martínez
ILIliana I León-Vega
Iliana I León-Vega
IGIdaira M Guerrero-Fonseca
Idaira M Guerrero-Fonseca
HVHilda Vargas-Robles
Hilda Vargas-Robles
KJKarina E Jiménez-Camacho
Karina E Jiménez-Camacho
MSMichael Schnoor
Michael Schnoor
T cell acute lymphoblastic leukemia (T-ALL) is an aggressive hematological malignancy that is still fatal in many cases. T cell blasts are characterized by hyperactivation and strong proliferative and migratory capacities. The chemokine receptor CXCR4 is involved in mediating malignant T cell properties, and cortactin has been shown to control CXCR4 surface localization in T-ALL cells. We have previously shown that cortactin overexpression is correlated with organ infiltration and relapse in B-ALL. However, the role of cortactin in T cell biology and T-ALL remains elusive. Here, we analyzed the functional relevance of cortactin for T cell activation and migration and the implications for T-ALL development. We found that cortactin is upregulated in response to T cell receptor engagement and recruited to the immune synapse in normal T cells. Loss of cortactin caused reduced IL-2 production and proliferation. Cortactin-depleted T cells showed defects in immune synapse formation and migrated less due to impaired actin polymerization in response to T cell receptor and CXCR4 stimulation. Leukemic T cells expressed much higher levels of cortactin compared to normal T cells that correlated with greater migratory capacity. Xenotransplantation assays in NSG mice revealed that cortactin-depleted human leukemic T cells colonized the bone marrow significantly less and failed to infiltrate the central nervous system, suggesting that cortactin overexpression drives organ infiltration, which is a major complication of T-ALL relapse. Thus, cortactin could serve as a potential therapeutic target for T-ALL and other pathologies involving aberrant T cell responses.

Verified
Journal Article
Open access
PDF file
MMMaricela Medrano-Silva
Maricela Medrano-Silva
ESEric Genaro Salmerón
Eric Genaro Salmerón
EAElena Arechaga-Ocampo
Elena Arechaga-Ocampo
NVNicolás Villegas-Sepúlveda
Nicolás Villegas-Sepúlveda
LSLeopoldo Santos-Argumedo
Leopoldo Santos-Argumedo
RHRosaura Hernández-Rivas
Rosaura Hernández-Rivas
Pancreatic cancer poses a major clinical challenge due to its aggressiveness, frequent recurrence, and limited response to current chemotherapeutic approaches. Cancer stem cells (CSCs), particularly pancreatic CSCs (PCSCs), are key drivers of tumor initiation, therapeutic resistance, and disease relapse. MicroRNAs (miRNAs) have emerged as critical regulators of CSC biology and influence self-renewal, pluripotency, and drug resistance through key signaling pathways. To identify PCSC-specific miRNAs, we enriched these cells using the pancreosphere culture method and isolated PCSC+ and PCSC− populations using FACS based on their expression of CD44, CD24, and CD133 surface markers. MicroRNA microarray analysis revealed 31 differentially expressed miRNAs (DEmiRNAs), of which 10 downregulated miRNAs were involved in pathways regulating pluripotency, including the Wnt/β-catenin, TGF-β, MAPK, and PI3K/AKT pathways. Then, 2 of these 10 DEmiRNAs, let-7b-5p and miR-24-3p, were selected for experimental validation. Their overexpression in PCSC+ cells inhibited these pathways, downregulated pluripotency factors, and induced differentiation into endocrine and exocrine phenotypes, as confirmed by RT-qPCR, Western blot, and RNA-seq. Functionally, each miRNA reduced sphere formation, increased gemcitabine sensitivity, and suppressed tumorigenicity in vivo, highlighting their potential as therapeutic candidates. Restoring tumor-suppressive miRNA expression may offer a novel strategy to overcome chemoresistance and improve outcomes in pancreatic cancer.

19 March 2025 in European Journal of Microbiology and Immunology
Verified
Journal Article
Open access
PDF file
APAraceli Perez-Lopez
Araceli Perez-Lopez
Gabriela Hernández-GaliciaGabriela Hernández-Galicia
Gabriela Hernández-Galicia
LLLuis Uriel Lopez-Bailon
Luis Uriel Lopez-Bailon
AGAna D. Gonzalez-Telona
Ana D. Gonzalez-Telona
RRRoberto Rosales-Reyes
Roberto Rosales-Reyes
Vianney Ortiz-NavarreteVianney Ortiz-Navarrete
Vianney Ortiz-Navarrete
B-cells serve as a niche for Salmonella to establish a chronic infection, enabling bacteria to evade immune responses. One mechanism Salmonella uses to survive inside B-cells involves inhibiting the NLRC4 inflammasome activation, thereby preventing pyroptotic cell death. This study investigates whether Salmonella-infected B-cells can mount bactericidal responses to control intracellular bacteria. Our results show that Salmonella-infected B-cells can produce and release TNFα, IL-6, and IL-10, but not RANTES. Furthermore, priming B-cells with TNFα, IL-1β, or IFNγ enhances their bactericidal activity by promoting the production of reactive oxygen and nitrogen production species, reducing intracellular load. These results suggest that B-cells can clear Salmonella infection within a pro-inflammatory environment. However, the concurrent production of IL-10 may counteract the effects of pro-inflammatory cytokines, potentially modulating the immune response in the microenvironment.

12 April 2025
Verified
Preprint
Open access
Gabriela Hernández-GaliciaGabriela Hernández-Galicia
Gabriela Hernández-Galicia
JPJocelyn C. Pérez-Lara
Jocelyn C. Pérez-Lara
IOIrlanda Olvera-Gomez
Irlanda Olvera-Gomez
Vianney Ortiz-NavarreteVianney Ortiz-Navarrete
Vianney Ortiz-Navarrete
CRTAM, an adhesion molecule with immunoregulatory properties, plays a crucial role in late-stage polarization processes, including the localization of proteins like CD44, talin, CD3, and PKC-ζ, as well as the secretion of cytokines such as IFN-γ, IL-17, and IL-22. These processes are essential for the development of memory CD8 T lymphocytes. This study aimed to investigate the impact of CRTAM expression on the generation of memory CD8 T lymphocytes. Our findings demonstrate that CRTAM is indispensable for establishing the CD8 effector memory subpopulation and maintaining CD8 central memory cells long-term after live bacteria immunization. Moreover, during the acute phase of the immune response against an attenuated strain of Salmonella , CRTAM expression promotes a transient KLRG1 + CD127 + phenotype. Furthermore, CRTAM influences protection against virulent Salmonella , impacting the frequency of CD8+ IFN-γ+ and Grz-B+ cells and CD8 T cell retention. Specifically, CRTAM deficiency diminishes the protective capacity and alters the balance of effector and memory CD8 T cell populations. These results collectively establish CRTAM as a crucial regulator of memory CD8 T cell subset dynamic, influencing both the establishment and maintenance of them while also playing a role in the acute and recall response.

28 January 2025 in Vaccines
Verified
Journal Article
Open access
PDF file
Noe Juvenal Mendoza-RamírezNoe Juvenal Mendoza-Ramírez
Noe Juvenal Mendoza-Ramírez
JCJulio García Cordero
Julio García Cordero
Gabriela Hernández-GaliciaGabriela Hernández-Galicia
Gabriela Hernández-Galicia
NMNicole Justine Moreno-Licona
Nicole Justine Moreno-Licona
Jesús HernándezJesús Hernández
Jesús Hernández
LCLeticia Cedillo-Barron
Leticia Cedillo-Barron
Background: Next-generation vaccines against coronavirus disease 2019 (COVID-19) focus on inducing a long-lasting immune response against severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) and its emerging variants. To achieve this, antigens other than spike proteins have been proposed, and different platforms have been evaluated. Nucleic acid-based vaccines are fundamental for this process. Preclinical data have shown that the SARS-CoV-2 nucleocapsid protein induces a protective cellular immune response, and when combined with the spike protein, the resulting humoral and cellular immune responses are effective against some SARS-CoV-2 variants. Methods: We designed a DNA vaccine against the spike and nucleocapsid proteins of SARS-CoV-2 to generate fusion proteins based on the Delta and Omicron B.5 strains. The most immunogenic regions of the spike and nucleocapsid proteins of the Delta and Omicron B strains were selected using bioinformatics. The nucleotide sequences were cloned into pcDNA3.1, and named pcDNA3.1/D-S1, pcDNA3.1/D-S1N, and pcDNA3.1/O-SN. The immunogenicity of the generated fusion proteins was evaluated by analyzing the humoral and cellular responses elicited after the immunization of BALB/c mice. Results: DNA immunization induced antibody production, neutralization activity, and IFN-γ production. The inclusion of the nucleocapsid regions in the plasmid greatly enhanced the immune response. Moreover, cross-reactions with the variants of interest were confirmed. Conclusions: Plasmids-encoding fusion proteins combining the most immunogenic regions of the spike and nucleocapsid proteins present a promising strategy for designing new and effective vaccines against SARS-CoV-2.

8 May 2024 in Journal of Leukocyte Biology
Verified
Journal Article
Closed access
PDF file
Gabriela Hernández-GaliciaGabriela Hernández-Galicia
Gabriela Hernández-Galicia
LGLuis Gomez-Morales
Luis Gomez-Morales
LLLuis Uriel Lopez-Bailon
Luis Uriel Lopez-Bailon
HVHumberto Valdovinos-Torres
Humberto Valdovinos-Torres
CCCarla O Contreras-Ochoa
Carla O Contreras-Ochoa
Vianney Ortiz-NavarreteVianney Ortiz-Navarrete
Vianney Ortiz-Navarrete
The immune response to SARS-CoV-2 has been extensively studied following the pandemic outbreak in 2020; however, the presence of specific T cells against SARS-CoV-2 before vaccination has not been evaluated in Mexico. In this study, we estimated the frequency of T CD4+ and T CD8+ cells that exhibit a specific response to S (spike) and N (nucleocapsid) proteins in a Mexican population. We collected 78 peripheral blood samples from unvaccinated subjects and the presence of antibodies against spike (RBD) and N protein was determined. PBMCs (peripheral blood mononuclear cells) were isolated and stimulated with a pool of S or N protein peptides (Wuhan-Hu-1 strain). IL-1β, IL-4, IL-6, IL-10, IL-2, IL-8, TNF-α, IFN-γ, and GM-CSF levels were quantified in the supernatant of the activated cells, and the cells were stained to assess the activation and memory phenotypes. Differential activation frequency dependent upon serological status was observed in CD4+ cells, but not in CD8+ cells. The predominantly activated population was the central memory T CD4+ cells. Only 10% of the population exhibited the same phenotype with respect to the response to nucleocapsid peptides. The cytokine profile differed between the S and N responses. S peptides induced a more proinflammatory response compared with the N peptides. In conclusion, in a Mexican cohort before vaccination, there was a significant response to the S and N SARS-CoV-2 proteins resulting from previous infections with seasonal coronaviruses or previous undetected exposure to SARS-CoV-2.